These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 5984518

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells.
    Wang Y, Sternfeld L, Yang F, Rodriguez JA, Ross C, Hayden MR, Carriere F, Liu G, Hofer W, Schulz I.
    Gut; 2009 Mar; 58(3):422-30. PubMed ID: 18936103
    [Abstract] [Full Text] [Related]

  • 4. [Lipoprotein lipase activity and PHLA inhibitors level in acute pancreatitis (author's transl)].
    Kinalska I, Gabryelewicz A, Langiewicz J.
    Przegl Lek; 1976 Mar; 33(2):311-5. PubMed ID: 1257514
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Lipid tolerance and lipoprotein lipases in normal persons and hypertriglyceridemia patients].
    Hansen W.
    Verh Dtsch Ges Inn Med; 1973 Mar; 79():1276-8. PubMed ID: 4790156
    [No Abstract] [Full Text] [Related]

  • 8. Idiopathic hyperlipidemia; search for a metabolic defect and its familial origin.
    Rozynkowa D, Paluszak J, Borowczyk T, Rakowski W.
    Pol Med J; 1967 Mar; 6(2):429-35. PubMed ID: 6030652
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome].
    Nikiforova NV.
    Biull Eksp Biol Med; 1966 Dec; 62(12):29-32. PubMed ID: 6005418
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hydrolysis of long-chain, n-3 fatty acid enriched chylomicrons by cardiac lipoprotein lipase.
    Levy R, Herzberg GR.
    Can J Physiol Pharmacol; 1999 Oct; 77(10):813-8. PubMed ID: 10588486
    [Abstract] [Full Text] [Related]

  • 14. [Hyperlipemia and tumors : post heparin lipase activity of the hamster bearing a malignant lymphoma].
    Beaumont V, Bérard M, Boisnier C, Beaumont JL.
    C R Acad Hebd Seances Acad Sci D; 1975 Feb 03; 280(5):665-8. PubMed ID: 809163
    [Abstract] [Full Text] [Related]

  • 15. [Research on experimental hyperlipemia. V. Compared effects of the incubation and of the clarifying factor on the blood serum].
    Tayeau F, Jouzier E.
    Bord Med; 1970 Sep 03; 3(9):2023-8. PubMed ID: 5481186
    [No Abstract] [Full Text] [Related]

  • 16. [Significance of lipoprotein lipase analysis in clinical tests].
    Ishibashi S.
    Nihon Rinsho; 1989 Dec 03; 48 Suppl():550-2. PubMed ID: 2621947
    [No Abstract] [Full Text] [Related]

  • 17. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
    Niu YG, Evans RD.
    Am J Physiol Endocrinol Metab; 2008 Nov 03; 295(5):E1106-16. PubMed ID: 18780778
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Familial hyperchylomicronemia or Type I hyperlipoproteinemia].
    Damgaard-Pedersen F, Dyerberg J.
    Ugeskr Laeger; 1974 Jan 14; 136(3):125-9. PubMed ID: 4840835
    [No Abstract] [Full Text] [Related]

  • 20. [Case of hypertriglyceridemia with impaired interactions between post heparin plasma lipase and chylomicrons].
    Taira M, Shirai K, Morisaki N, Saito Y, Kumagai A, Matusuoka N, Uemura S.
    Nihon Naika Gakkai Zasshi; 1983 Jun 14; 72(6):796-802. PubMed ID: 6655335
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.